E2F1 and melanoma: Thus, our findings indicate that AT-9283 safeguards the Rb-E2F complex by inhibiting Rb1 protein phosphorylation, thereby repressing the activity of transcription factor E2F-1 and blocking the G1-to-S phase transition in human melanoma A375P cells.